Partner Content Partner Content Pharmaceutical Microbiology UK CONFEX takes place in less th... Pharma Micro UK CONFEX takes place less than week
Partner Content Partner Content A personal invite from James Drinkwater to attend Pharmaceut... Invite from James Dirnkwater to join Pharma Micro EC
Partner Content Partner Content Exclusive interview from Sanofi Pasteur, speaker at SMi's Ph... Exclusive speaker interview released from Sanofi Pasteu
Partner Content Partner Content Pharmaceutical Microbiology UK Speaker Interview Released fr... Pharmaceutical Microbiology UK Speaker Interview PR
Partner Content Partner Content Agenda released - Pharmaceutical Microbiology 2019 announces... Agenda for Pharma Micro UK
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.